Who do you relate to more when it comes to diabetes management? An angel who follows the recommended guidelines (Jeremy/Gallant), or a stubborn hellion easily influenced by temptation (Steve/Goofus)? Check out some of these scenarios from Dr. E. and see if you are who you think you are.
[read_more text="read more" title="read more" url="https://tcoyd.org/2021/01/the-goofus-and-gallant-of-diabetes/" align="left"]
With newer medication options available now for treating type 2 diabetes, Dr. Edelman answers a common question about how they can be included in a diabetes management regimen with regard to metformin.
[read_more text="read more" title="read more" url="https://tcoyd.org/2020/08/are-glp-1s-and-sglt2s-replacements-for-metformin-or-in-addition-to-metformin/" align="left"]
New and exciting treatment strategies are available now to help manage type 2 diabetes, and the options allow for customizable plans so you can find the best therapies to fit your individual needs. Watch this recording of our Spotlight Type 2 night to hear the latest in T2D treatments!
[read_more text="read more" title="read more" url="https://tcoyd.org/2020/07/spotlight-type-2-night-video-recording/" align="left"]
Trijardy is the first triple combo pill for people with type 2 diabetes that combines three meds in one. It helps reduce blood sugar, promote weight loss, improve blood pressure and reduce the risk of coronary artery disease, renal disease and strokes.
[read_more text="read more" title="read more" url="https://tcoyd.org/2020/03/trijardy-xr-the-first-triple-combo-pill-for-type-2-diabetes/" align="left"]
The use of DPP-4 inhibitors (Januvia, Onglyza, Tradjenta and Nesina) has been so widespread because these medications come in a pill, only need to be taken once a day and have few side effects.
[read_more text="read more" title="read more" url="https://tcoyd.org/2019/01/evaluating-type-2-medications-part-4-dpp-4-inhibitors-or-incretin-enhancers/" align="left"]
